Stay updated with breaking news from Bernard Gilly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
16.01.2024 - Regulatory News: The Board of Directors of GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (the 'Company'), a biopharma company focused on developing and commercializing innovative gene therapies for retinal ...
PRESS RELEASE GenSight Biologics appoints Laurence Rodriguez as Chief Executive Officer Paris, France, December 22,...
GenSight Biologics shares were up on Friday morning after the struggling biopharmaceutical company announced the appointment of Laurence Rodriguez, a former Sanofi Genzyme executive, as its new CEO.At...
Compensation policy of the Chief Executive Officer and/or any other corporate officer This compensation policy has been approved by the Combined General Meeting held on June 21, 2023, in its 7th resolution, by a major...
Results of the Annual General Shareholder Meeting as of June 13, 2023 Paris, France, June 15, 2023 – 07:00 CET – The Annual General Shareholder Meeting of Pixium... | June 15, 2023